25 XP   0   0   10

Beijing Wantai Biological Pharmacy Enterprise Co Ltd
Buy, Hold or Sell?

Let's analyse Beijing Wantai Biological Pharmacy Enterprise Co Ltd together

PenkeI guess you are interested in Beijing Wantai Biological Pharmacy Enterprise Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Beijing Wantai Biological Pharmacy Enterprise Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Beijing Wantai Biological Pharmacy Enterprise Co Ltd

I send you an email if I find something interesting about Beijing Wantai Biological Pharmacy Enterprise Co Ltd.

Quick analysis of Beijing Wantai Biological Pharmacy Enterprise Co Ltd (30 sec.)










What can you expect buying and holding a share of Beijing Wantai Biological Pharmacy Enterprise Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.10
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥10.16
Expected worth in 1 year
¥10.41
How sure are you?
94.1%

+ What do you gain per year?

Total Gains per Share
¥1.00
Return On Investment
1.5%

For what price can you sell your share?

Current Price per Share
¥64.64
Expected price per share
¥50.20 - ¥89.54
How sure are you?
50%

1. Valuation of Beijing Wantai Biological Pharmacy Enterprise Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥64.64

Intrinsic Value Per Share

¥17.09 - ¥20.10

Total Value Per Share

¥27.25 - ¥30.26

2. Growth of Beijing Wantai Biological Pharmacy Enterprise Co Ltd (5 min.)




Is Beijing Wantai Biological Pharmacy Enterprise Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$1.7b$1.4b$434.8m23.5%

How much money is Beijing Wantai Biological Pharmacy Enterprise Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$43m$163.3m-$120.3m-279.6%
Net Profit Margin-2.8%42.1%--

How much money comes from the company's main activities?

3. Financial Health of Beijing Wantai Biological Pharmacy Enterprise Co Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#39 / 1010

Most Revenue
#71 / 1010

Most Profit
#53 / 1010

Most Efficient
#449 / 1010

What can you expect buying and holding a share of Beijing Wantai Biological Pharmacy Enterprise Co Ltd? (5 min.)

Welcome investor! Beijing Wantai Biological Pharmacy Enterprise Co Ltd's management wants to use your money to grow the business. In return you get a share of Beijing Wantai Biological Pharmacy Enterprise Co Ltd.

What can you expect buying and holding a share of Beijing Wantai Biological Pharmacy Enterprise Co Ltd?

First you should know what it really means to hold a share of Beijing Wantai Biological Pharmacy Enterprise Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Beijing Wantai Biological Pharmacy Enterprise Co Ltd is ¥64.64. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Beijing Wantai Biological Pharmacy Enterprise Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Beijing Wantai Biological Pharmacy Enterprise Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥10.16. Based on the TTM, the Book Value Change Per Share is ¥0.06 per quarter. Based on the YOY, the Book Value Change Per Share is ¥1.58 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.19 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Beijing Wantai Biological Pharmacy Enterprise Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps-0.06-0.1%0.030.1%0.130.2%0.060.1%0.060.1%
Usd Book Value Change Per Share-0.07-0.1%0.010.0%0.220.3%0.080.1%0.080.1%
Usd Dividend Per Share0.000.0%0.030.0%0.000.0%0.010.0%0.010.0%
Usd Total Gains Per Share-0.07-0.1%0.030.1%0.220.3%0.090.1%0.090.1%
Usd Price Per Share10.37-10.56-23.27-20.11-20.11-
Price to Earnings Ratio-42.48-44.22-45.52-112.84-112.84-
Price-to-Total Gains Ratio-156.33-154.62-156.49-441.45-441.45-
Price to Book Ratio7.40-7.23-25.71-45.58-45.58-
Price-to-Total Gains Ratio-156.33-154.62-156.49-441.45-441.45-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share8.92032
Number of shares112
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.030.01
Usd Book Value Change Per Share0.010.08
Usd Total Gains Per Share0.030.09
Gains per Quarter (112 shares)3.8710.09
Gains per Year (112 shares)15.4740.37
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1124533730
22382077470
335123510111110
446165014148150
558196517185190
670238021222230
781279524259270
8933111027296310
91043512531333350
101163914034369390

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%11.01.00.091.7%16.01.00.094.1%16.01.00.094.1%16.01.00.094.1%
Book Value Change Per Share2.02.00.050.0%10.02.00.083.3%15.02.00.088.2%15.02.00.088.2%15.02.00.088.2%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%17.00.00.0100.0%17.00.00.0100.0%17.00.00.0100.0%
Total Gains per Share3.01.00.075.0%11.01.00.091.7%16.01.00.094.1%16.01.00.094.1%16.01.00.094.1%

Fundamentals of Beijing Wantai Biological Pharmacy Enterprise Co Ltd

About Beijing Wantai Biological Pharmacy Enterprise Co Ltd

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. researches, develops, produces, distributes, and sells infectious disease diagnostic reagents and vaccines in China and internationally. The company provides COVID 19, HIV and HTLV, Hepatitis, EV-71, and Tuberculosis diagnostics test kits; Hepatitis C and Syphilis detection reagents; automated immunoassays; ELISA kits and rapid tests for infectious disease diagnostics; chemiluminescence and clinical chemistry reagents; immunodiagnostic reagents; and Hepatitis E and human papillomavirus vaccines. It serves blood banks, hospitals and clinics, reference laboratories, border inspection centers, blood-processing companies, and research institutes. The company was founded in 1991 and is headquartered in Beijing, China.

Fundamental data was last updated by Penke on 2024-04-18 12:39:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is fair priced.

1.1. Profitability of Beijing Wantai Biological Pharmacy Enterprise Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Beijing Wantai Biological Pharmacy Enterprise Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Beijing Wantai Biological Pharmacy Enterprise Co Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -103.5% means that ¥-1.03 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Beijing Wantai Biological Pharmacy Enterprise Co Ltd:

  • The MRQ is -103.5%. The company is making a huge loss. -2
  • The TTM is -2.8%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-103.5%TTM-2.8%-100.6%
TTM-2.8%YOY42.1%-45.0%
TTM-2.8%5Y25.5%-28.4%
5Y25.5%10Y25.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-103.5%-200.1%+96.6%
TTM-2.8%-216.8%+214.0%
YOY42.1%-288.3%+330.4%
5Y25.5%-449.1%+474.6%
10Y25.5%-605.5%+631.0%
1.1.2. Return on Assets

Shows how efficient Beijing Wantai Biological Pharmacy Enterprise Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Beijing Wantai Biological Pharmacy Enterprise Co Ltd to the Biotechnology industry mean.
  • -3.6% Return on Assets means that Beijing Wantai Biological Pharmacy Enterprise Co Ltd generated ¥-0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Beijing Wantai Biological Pharmacy Enterprise Co Ltd:

  • The MRQ is -3.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is 1.8%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ-3.6%TTM1.8%-5.3%
TTM1.8%YOY9.3%-7.6%
TTM1.8%5Y6.4%-4.6%
5Y6.4%10Y6.4%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.6%-13.3%+9.7%
TTM1.8%-12.8%+14.6%
YOY9.3%-11.7%+21.0%
5Y6.4%-13.9%+20.3%
10Y6.4%-15.7%+22.1%
1.1.3. Return on Equity

Shows how efficient Beijing Wantai Biological Pharmacy Enterprise Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Beijing Wantai Biological Pharmacy Enterprise Co Ltd to the Biotechnology industry mean.
  • -4.4% Return on Equity means Beijing Wantai Biological Pharmacy Enterprise Co Ltd generated ¥-0.04 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Beijing Wantai Biological Pharmacy Enterprise Co Ltd:

  • The MRQ is -4.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is 2.3%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ-4.4%TTM2.3%-6.7%
TTM2.3%YOY13.3%-11.0%
TTM2.3%5Y9.0%-6.8%
5Y9.0%10Y9.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.4%-16.9%+12.5%
TTM2.3%-16.1%+18.4%
YOY13.3%-15.1%+28.4%
5Y9.0%-19.3%+28.3%
10Y9.0%-20.2%+29.2%

1.2. Operating Efficiency of Beijing Wantai Biological Pharmacy Enterprise Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Beijing Wantai Biological Pharmacy Enterprise Co Ltd is operating .

  • Measures how much profit Beijing Wantai Biological Pharmacy Enterprise Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Beijing Wantai Biological Pharmacy Enterprise Co Ltd to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Beijing Wantai Biological Pharmacy Enterprise Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM20.3%-20.3%
TTM20.3%YOY46.5%-26.2%
TTM20.3%5Y33.2%-12.9%
5Y33.2%10Y33.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--296.2%+296.2%
TTM20.3%-232.5%+252.8%
YOY46.5%-298.2%+344.7%
5Y33.2%-492.1%+525.3%
10Y33.2%-632.4%+665.6%
1.2.2. Operating Ratio

Measures how efficient Beijing Wantai Biological Pharmacy Enterprise Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.88 means that the operating costs are ¥1.88 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Beijing Wantai Biological Pharmacy Enterprise Co Ltd:

  • The MRQ is 1.875. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.123. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.875TTM1.123+0.752
TTM1.123YOY0.609+0.514
TTM1.1235Y0.841+0.282
5Y0.84110Y0.8410.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8753.231-1.356
TTM1.1233.310-2.187
YOY0.6093.890-3.281
5Y0.8415.739-4.898
10Y0.8417.876-7.035

1.3. Liquidity of Beijing Wantai Biological Pharmacy Enterprise Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Beijing Wantai Biological Pharmacy Enterprise Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.86 means the company has ¥3.86 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Beijing Wantai Biological Pharmacy Enterprise Co Ltd:

  • The MRQ is 3.858. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.984. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.858TTM3.984-0.125
TTM3.984YOY3.140+0.844
TTM3.9845Y2.837+1.146
5Y2.83710Y2.8370.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.8583.890-0.032
TTM3.9844.173-0.189
YOY3.1405.344-2.204
5Y2.8376.126-3.289
10Y2.8376.448-3.611
1.3.2. Quick Ratio

Measures if Beijing Wantai Biological Pharmacy Enterprise Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Beijing Wantai Biological Pharmacy Enterprise Co Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 1.89 means the company can pay off ¥1.89 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Beijing Wantai Biological Pharmacy Enterprise Co Ltd:

  • The MRQ is 1.890. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.173. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.890TTM2.173-0.283
TTM2.173YOY1.575+0.597
TTM2.1735Y1.370+0.803
5Y1.37010Y1.3700.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8903.514-1.624
TTM2.1733.998-1.825
YOY1.5755.380-3.805
5Y1.3706.105-4.735
10Y1.3706.404-5.034

1.4. Solvency of Beijing Wantai Biological Pharmacy Enterprise Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Beijing Wantai Biological Pharmacy Enterprise Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Beijing Wantai Biological Pharmacy Enterprise Co Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.18 means that Beijing Wantai Biological Pharmacy Enterprise Co Ltd assets are financed with 18.0% credit (debt) and the remaining percentage (100% - 18.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Beijing Wantai Biological Pharmacy Enterprise Co Ltd:

  • The MRQ is 0.180. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.187. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.180TTM0.187-0.007
TTM0.187YOY0.260-0.073
TTM0.1875Y0.252-0.065
5Y0.25210Y0.2520.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1800.339-0.159
TTM0.1870.336-0.149
YOY0.2600.271-0.011
5Y0.2520.366-0.114
10Y0.2520.389-0.137
1.4.2. Debt to Equity Ratio

Measures if Beijing Wantai Biological Pharmacy Enterprise Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Beijing Wantai Biological Pharmacy Enterprise Co Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 22.3% means that company has ¥0.22 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Beijing Wantai Biological Pharmacy Enterprise Co Ltd:

  • The MRQ is 0.223. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.234. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.223TTM0.234-0.011
TTM0.234YOY0.366-0.132
TTM0.2345Y0.349-0.115
5Y0.34910Y0.3490.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2230.388-0.165
TTM0.2340.402-0.168
YOY0.3660.335+0.031
5Y0.3490.426-0.077
10Y0.3490.461-0.112

2. Market Valuation of Beijing Wantai Biological Pharmacy Enterprise Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Beijing Wantai Biological Pharmacy Enterprise Co Ltd generates.

  • Above 15 is considered overpriced but always compare Beijing Wantai Biological Pharmacy Enterprise Co Ltd to the Biotechnology industry mean.
  • A PE ratio of -42.48 means the investor is paying ¥-42.48 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Beijing Wantai Biological Pharmacy Enterprise Co Ltd:

  • The EOD is -36.552. Based on the earnings, the company is expensive. -2
  • The MRQ is -42.484. Based on the earnings, the company is expensive. -2
  • The TTM is 44.220. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD-36.552MRQ-42.484+5.932
MRQ-42.484TTM44.220-86.704
TTM44.220YOY45.524-1.304
TTM44.2205Y112.839-68.620
5Y112.83910Y112.8390.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-36.552-2.264-34.288
MRQ-42.484-2.629-39.855
TTM44.220-2.680+46.900
YOY45.524-4.145+49.669
5Y112.839-6.257+119.096
10Y112.839-6.254+119.093
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Beijing Wantai Biological Pharmacy Enterprise Co Ltd:

  • The EOD is 57.854. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 67.243. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 31.914. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD57.854MRQ67.243-9.389
MRQ67.243TTM31.914+35.328
TTM31.914YOY188.943-157.028
TTM31.9145Y-125.097+157.012
5Y-125.09710Y-125.0970.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD57.854-2.973+60.827
MRQ67.243-3.333+70.576
TTM31.914-3.553+35.467
YOY188.943-5.605+194.548
5Y-125.097-8.376-116.721
10Y-125.097-8.865-116.232
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Beijing Wantai Biological Pharmacy Enterprise Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 7.40 means the investor is paying ¥7.40 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Beijing Wantai Biological Pharmacy Enterprise Co Ltd:

  • The EOD is 6.363. Based on the equity, the company is overpriced. -1
  • The MRQ is 7.395. Based on the equity, the company is overpriced. -1
  • The TTM is 7.230. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD6.363MRQ7.395-1.033
MRQ7.395TTM7.230+0.165
TTM7.230YOY25.711-18.481
TTM7.2305Y45.580-38.350
5Y45.58010Y45.5800.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD6.3631.896+4.467
MRQ7.3952.115+5.280
TTM7.2302.093+5.137
YOY25.7112.884+22.827
5Y45.5803.542+42.038
10Y45.5803.916+41.664
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Beijing Wantai Biological Pharmacy Enterprise Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.4820.063-867%1.577-131%0.598-181%0.598-181%
Book Value Per Share--10.15910.555-4%8.070+26%5.526+84%5.526+84%
Current Ratio--3.8583.984-3%3.140+23%2.837+36%2.837+36%
Debt To Asset Ratio--0.1800.187-4%0.260-31%0.252-29%0.252-29%
Debt To Equity Ratio--0.2230.234-5%0.366-39%0.349-36%0.349-36%
Dividend Per Share--0.0010.187-99%0.025-95%0.055-98%0.055-98%
Eps---0.4420.246-280%0.934-147%0.407-209%0.407-209%
Free Cash Flow Per Share--0.2790.075+275%0.631-56%0.212+32%0.212+32%
Free Cash Flow To Equity Per Share--0.279-0.267+196%1.248-78%0.302-7%0.302-7%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--20.101--------
Intrinsic Value_10Y_min--17.087--------
Intrinsic Value_1Y_max--1.241--------
Intrinsic Value_1Y_min--1.218--------
Intrinsic Value_3Y_max--4.318--------
Intrinsic Value_3Y_min--4.110--------
Intrinsic Value_5Y_max--8.105--------
Intrinsic Value_5Y_min--7.472--------
Market Cap81977097502.720-16%95280620906.24097027580247.360-2%213820214092.800-55%184773735418.196-48%184773735418.196-48%
Net Profit Margin---1.035-0.028-97%0.421-346%0.255-506%0.255-506%
Operating Margin---0.203-100%0.465-100%0.332-100%0.332-100%
Operating Ratio--1.8751.123+67%0.609+208%0.841+123%0.841+123%
Pb Ratio6.363-16%7.3957.230+2%25.711-71%45.580-84%45.580-84%
Pe Ratio-36.552+14%-42.48444.220-196%45.524-193%112.839-138%112.839-138%
Price Per Share64.640-16%75.13076.508-2%168.600-55%145.696-48%145.696-48%
Price To Free Cash Flow Ratio57.854-16%67.24331.914+111%188.943-64%-125.097+286%-125.097+286%
Price To Total Gains Ratio-134.502+14%-156.329154.618-201%156.493-200%441.447-135%441.447-135%
Quick Ratio--1.8902.173-13%1.575+20%1.370+38%1.370+38%
Return On Assets---0.0360.018-302%0.093-138%0.064-156%0.064-156%
Return On Equity---0.0440.023-296%0.133-133%0.090-149%0.090-149%
Total Gains Per Share---0.4810.250-292%1.603-130%0.653-174%0.653-174%
Usd Book Value--1777944700.5041847285309.090-4%1412408656.379+26%967094733.713+84%967094733.713+84%
Usd Book Value Change Per Share---0.0660.009-867%0.218-131%0.082-181%0.082-181%
Usd Book Value Per Share--1.4021.457-4%1.114+26%0.763+84%0.763+84%
Usd Dividend Per Share--0.0000.026-99%0.003-95%0.008-98%0.008-98%
Usd Eps---0.0610.034-280%0.129-147%0.056-209%0.056-209%
Usd Free Cash Flow--48885243.40813046218.047+275%110492527.157-56%34847120.689+40%34847120.689+40%
Usd Free Cash Flow Per Share--0.0390.010+275%0.087-56%0.029+32%0.029+32%
Usd Free Cash Flow To Equity Per Share--0.039-0.037+196%0.172-78%0.042-7%0.042-7%
Usd Market Cap11312839455.375-16%13148725685.06113389806074.136-2%29507189544.806-55%25498775487.711-48%25498775487.711-48%
Usd Price Per Share8.920-16%10.36810.558-2%23.267-55%20.106-48%20.106-48%
Usd Profit---77374459.57243044950.471-280%163384935.901-147%71157377.682-209%71157377.682-209%
Usd Revenue--74780516.262190121996.695-61%385889010.679-81%204191344.672-63%204191344.672-63%
Usd Total Gains Per Share---0.0660.035-292%0.221-130%0.090-174%0.090-174%
 EOD+4 -4MRQTTM+9 -26YOY+11 -245Y+13 -2210Y+13 -22

3.2. Fundamental Score

Let's check the fundamental score of Beijing Wantai Biological Pharmacy Enterprise Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-36.552
Price to Book Ratio (EOD)Between0-16.363
Net Profit Margin (MRQ)Greater than0-1.035
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.890
Current Ratio (MRQ)Greater than13.858
Debt to Asset Ratio (MRQ)Less than10.180
Debt to Equity Ratio (MRQ)Less than10.223
Return on Equity (MRQ)Greater than0.15-0.044
Return on Assets (MRQ)Greater than0.05-0.036
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Beijing Wantai Biological Pharmacy Enterprise Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.373
Ma 20Greater thanMa 5068.563
Ma 50Greater thanMa 10068.975
Ma 100Greater thanMa 20065.105
OpenGreater thanClose66.050
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Income before Tax  876,645556,7881,433,433-932,210501,223-433,11568,107-677,479-609,372
Net Income  791,989452,9291,244,918-787,478457,440-351,434106,006-666,691-560,684
Net Income from Continuing Operations  823,993428,7501,252,743-796,156456,587-354,151102,436-667,697-565,261



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets15,714,998
Total Liabilities2,831,341
Total Stockholder Equity12,700,598
 As reported
Total Liabilities 2,831,341
Total Stockholder Equity+ 12,700,598
Total Assets = 15,714,998

Assets

Total Assets15,714,998
Total Current Assets10,302,075
Long-term Assets5,412,923
Total Current Assets
Cash And Cash Equivalents 3,818,319
Short-term Investments 2,055,361
Net Receivables 2,990,889
Inventory 905,485
Other Current Assets 495,148
Total Current Assets  (as reported)10,302,075
Total Current Assets  (calculated)10,265,202
+/- 36,873
Long-term Assets
Property Plant Equipment 2,640,975
Intangible Assets 642,745
Long-term Assets Other 459,408
Long-term Assets  (as reported)5,412,923
Long-term Assets  (calculated)3,743,127
+/- 1,669,795

Liabilities & Shareholders' Equity

Total Current Liabilities2,669,975
Long-term Liabilities161,366
Total Stockholder Equity12,700,598
Total Current Liabilities
Short Long Term Debt 81,140
Accounts payable 389,593
Other Current Liabilities 3,758
Total Current Liabilities  (as reported)2,669,975
Total Current Liabilities  (calculated)474,491
+/- 2,195,484
Long-term Liabilities
Long term Debt 115,356
Capital Lease Obligations Min Short Term Debt12,363
Long-term Liabilities  (as reported)161,366
Long-term Liabilities  (calculated)127,719
+/- 33,647
Total Stockholder Equity
Retained Earnings 7,574,801
Total Stockholder Equity (as reported)12,700,598
Total Stockholder Equity (calculated)7,574,801
+/- 5,125,797
Other
Capital Stock1,268,207
Common Stock Shares Outstanding 1,268,207
Net Invested Capital 12,897,094
Net Working Capital 7,632,100
Property Plant and Equipment Gross 2,640,975



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-03-312018-12-312018-09-30
> Total Assets 
0
0
0
2,164,920
2,194,450
2,828,554
3,184,990
3,503,683
3,906,888
4,408,391
5,485,589
7,045,948
9,119,323
14,045,920
15,215,828
16,229,517
17,253,877
16,476,702
16,464,312
15,714,998
15,714,99816,464,31216,476,70217,253,87716,229,51715,215,82814,045,9209,119,3237,045,9485,485,5894,408,3913,906,8883,503,6833,184,9902,828,5542,194,4502,164,920000
   > Total Current Assets 
0
0
0
885,659
893,946
1,469,854
1,750,345
1,977,790
2,237,705
2,527,863
3,495,615
4,646,602
6,452,644
10,913,236
11,639,929
12,179,759
12,919,450
11,984,150
11,032,568
10,302,075
10,302,07511,032,56811,984,15012,919,45012,179,75911,639,92910,913,2366,452,6444,646,6023,495,6152,527,8632,237,7051,977,7901,750,3451,469,854893,946885,659000
       Cash And Cash Equivalents 
0
0
0
283,601
214,456
661,299
666,866
710,666
596,222
714,548
690,946
1,415,316
1,608,005
5,377,690
4,662,467
5,192,248
4,371,171
3,712,373
3,668,274
3,818,319
3,818,3193,668,2743,712,3734,371,1715,192,2484,662,4675,377,6901,608,0051,415,316690,946714,548596,222710,666666,866661,299214,456283,601000
       Short-term Investments 
0
0
0
58,001
18,098
76,255
36,255
50,361
50,371
371
20,435
40,389
30,689
450,389
1,953,883
2,008,613
2,112,754
2,218,962
2,048,102
2,055,361
2,055,3612,048,1022,218,9622,112,7542,008,6131,953,883450,38930,68940,38920,43537150,37150,36136,25576,25518,09858,001000
       Net Receivables 
0
0
0
251,494
280,006
378,673
649,150
718,583
1,003,466
1,212,062
1,930,109
2,292,154
3,847,840
4,123,735
4,232,379
3,970,072
5,172,606
4,719,605
3,973,068
2,990,889
2,990,8893,973,0684,719,6055,172,6063,970,0724,232,3794,123,7353,847,8402,292,1541,930,1091,212,0621,003,466718,583649,150378,673280,006251,494000
       Other Current Assets 
0
0
0
22,920
95,144
17,607
29,193
44,945
144,329
57,495
315,135
105,203
93,315
78,349
73,479
139,398
259,277
149,559
158,676
495,148
495,148158,676149,559259,277139,39873,47978,34993,315105,203315,13557,495144,32944,94529,19317,60795,14422,920000
   > Long-term Assets 
0
0
0
1,279,260
1,300,504
1,358,701
1,434,646
1,525,894
1,669,183
1,880,528
1,989,974
2,399,346
2,666,679
3,132,683
3,575,898
4,049,757
4,334,427
4,492,552
5,431,744
5,412,923
5,412,9235,431,7444,492,5524,334,4274,049,7573,575,8983,132,6832,666,6792,399,3461,989,9741,880,5281,669,1831,525,8941,434,6461,358,7011,300,5041,279,260000
       Property Plant Equipment 
584,526
584,526
0
0
623,637
673,070
729,955
790,977
942,137
1,170,820
1,360,520
1,702,886
1,825,251
1,960,754
2,067,339
2,235,293
2,294,706
2,413,420
2,575,899
2,640,975
2,640,9752,575,8992,413,4202,294,7062,235,2932,067,3391,960,7541,825,2511,702,8861,360,5201,170,820942,137790,977729,955673,070623,63700584,526584,526
       Intangible Assets 
0
0
0
242,031
239,665
237,743
235,455
233,947
231,542
290,920
287,854
295,127
456,696
628,363
759,403
332,376
353,135
601,628
616,492
642,745
642,745616,492601,628353,135332,376759,403628,363456,696295,127287,854290,920231,542233,947235,455237,743239,665242,031000
       Long-term Assets Other 
0
0
0
263,493
297,643
336,766
1,108,670
412,700
409,874
329,685
248,129
299,092
274,418
220,695
310,554
372,297
671,754
467,669
510,101
459,408
459,408510,101467,669671,754372,297310,554220,695274,418299,092248,129329,685409,874412,7001,108,670336,766297,643263,493000
> Total Liabilities 
0
0
0
584,190
542,946
682,629
815,861
923,287
1,034,684
1,206,705
1,798,679
2,483,457
3,170,064
3,366,048
3,470,469
3,664,625
3,476,242
3,088,150
2,969,654
2,831,341
2,831,3412,969,6543,088,1503,476,2423,664,6253,470,4693,366,0483,170,0642,483,4571,798,6791,206,7051,034,684923,287815,861682,629542,946584,190000
   > Total Current Liabilities 
0
0
0
492,031
443,461
610,405
741,161
829,026
930,033
1,097,529
1,666,990
2,365,729
3,001,753
3,207,882
3,313,070
3,485,190
3,277,283
2,892,287
2,763,868
2,669,975
2,669,9752,763,8682,892,2873,277,2833,485,1903,313,0703,207,8823,001,7532,365,7291,666,9901,097,529930,033829,026741,161610,405443,461492,031000
       Short Long Term Debt 
0
0
0
0
20,534
90,367
77,599
77,656
77,308
76,793
195,503
235,638
284,834
215,081
60,000
140,139
150,110
129,960
108,806
81,140
81,140108,806129,960150,110140,13960,000215,081284,834235,638195,50376,79377,30877,65677,59990,36720,5340000
       Accounts payable 
0
0
0
85,047
95,054
89,545
88,536
112,738
101,026
101,882
96,970
154,081
196,808
267,803
238,939
275,468
336,743
268,037
308,519
389,593
389,593308,519268,037336,743275,468238,939267,803196,808154,08196,970101,882101,026112,73888,53689,54595,05485,047000
       Other Current Liabilities 
0
0
0
0
287,910
193,382
499,157
197,830
672,527
215,444
1,197,940
421,487
2,374,198
549,934
2,756,064
480,646
2,416,137
429,169
414
3,758
3,758414429,1692,416,137480,6462,756,064549,9342,374,198421,4871,197,940215,444672,527197,830499,157193,382287,9100000
   > Long-term Liabilities 
0
0
0
92,160
99,486
72,224
74,699
94,260
104,651
109,176
131,689
117,728
168,311
158,166
157,400
179,435
198,959
195,864
205,785
161,366
161,366205,785195,864198,959179,435157,400158,166168,311117,728131,689109,176104,65194,26074,69972,22499,48692,160000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
24,112
18,128
35,648
32,592
32,681
30,184
29,236
18,428
19,157
16,156
15,639
12,363
12,36315,63916,15619,15718,42829,23630,18432,68132,59235,64818,12824,11200000000
       Long-term Liabilities Other 
0
0
0
0
21,000
0
0
0
0
0
0
3,800
3,800
3,800
3,800
0
0
0
0
0
000003,8003,8003,8003,80000000021,0000000
       Deferred Long Term Liability 
27,521
27,521
0
0
17,215
16,568
16,293
27,759
25,147
30,760
23,305
27,178
185,715
360,996
491,764
164,644
0
204,098
0
0
00204,0980164,644491,764360,996185,71527,17823,30530,76025,14727,75916,29316,56817,2150027,52127,521
> Total Stockholder Equity
0
0
0
1,558,820
1,629,256
2,120,521
2,343,405
2,553,669
2,842,882
3,166,774
3,633,021
4,466,287
5,797,192
10,497,976
11,554,253
12,341,257
13,586,175
13,197,946
13,307,623
12,700,598
12,700,59813,307,62313,197,94613,586,17512,341,25711,554,25310,497,9765,797,1924,466,2873,633,0213,166,7742,842,8822,553,6692,343,4052,120,5211,629,2561,558,820000
   Common Stock
390,000
390,000
0
0
390,000
433,600
433,600
433,600
433,600
607,040
607,040
607,040
607,040
906,071
906,071
906,071
906,071
1,268,207
0
0
001,268,207906,071906,071906,071906,071607,040607,040607,040607,040433,600433,600433,600433,600390,00000390,000390,000
   Retained Earnings Total Equity00000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000
   Capital Surplus 00000000000000000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 00000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue5,510,783
Cost of Revenue-792,125
Gross Profit4,718,6584,718,658
 
Operating Income (+$)
Gross Profit4,718,658
Operating Expense-3,888,900
Operating Income1,621,882829,758
 
Operating Expense (+$)
Research Development1,197,930
Selling General Administrative1,638,801
Selling And Marketing Expenses0
Operating Expense3,888,9002,836,732
 
Net Interest Income (+$)
Interest Income87,977
Interest Expense-6,860
Other Finance Cost-1,154
Net Interest Income79,963
 
Pretax Income (+$)
Operating Income1,621,882
Net Interest Income79,963
Other Non-Operating Income Expenses0
Income Before Tax (EBT)1,393,3921,621,882
EBIT - interestExpense = -6,860
1,247,680
1,254,540
Interest Expense6,860
Earnings Before Interest and Taxes (EBIT)01,400,252
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax1,393,392
Tax Provision-146,887
Net Income From Continuing Ops1,246,5041,246,504
Net Income1,247,680
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-79,963
 

Technical Analysis of Beijing Wantai Biological Pharmacy Enterprise Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Beijing Wantai Biological Pharmacy Enterprise Co Ltd. The general trend of Beijing Wantai Biological Pharmacy Enterprise Co Ltd is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Beijing Wantai Biological Pharmacy Enterprise Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Beijing Wantai Biological Pharmacy Enterprise Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 81.50 < 88.00 < 89.54.

The bearish price targets are: 63.41 > 50.27 > 50.20.

Tweet this
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Beijing Wantai Biological Pharmacy Enterprise Co Ltd. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Beijing Wantai Biological Pharmacy Enterprise Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Beijing Wantai Biological Pharmacy Enterprise Co Ltd. The current macd is -0.86530565.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Beijing Wantai Biological Pharmacy Enterprise Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Beijing Wantai Biological Pharmacy Enterprise Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Beijing Wantai Biological Pharmacy Enterprise Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartBeijing Wantai Biological Pharmacy Enterprise Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Beijing Wantai Biological Pharmacy Enterprise Co Ltd. The current adx is 14.22.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Beijing Wantai Biological Pharmacy Enterprise Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Beijing Wantai Biological Pharmacy Enterprise Co Ltd. The current sar is 80.19.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Beijing Wantai Biological Pharmacy Enterprise Co Ltd. The current rsi is 41.37. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Daily Relative Strength Index (RSI) ChartBeijing Wantai Biological Pharmacy Enterprise Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Beijing Wantai Biological Pharmacy Enterprise Co Ltd. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Beijing Wantai Biological Pharmacy Enterprise Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Daily Stochastic Oscillator ChartBeijing Wantai Biological Pharmacy Enterprise Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Beijing Wantai Biological Pharmacy Enterprise Co Ltd. The current cci is -99.52101252.

Beijing Wantai Biological Pharmacy Enterprise Co Ltd Daily Commodity Channel Index (CCI) ChartBeijing Wantai Biological Pharmacy Enterprise Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Beijing Wantai Biological Pharmacy Enterprise Co Ltd. The current cmo is -27.32771207.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Daily Chande Momentum Oscillator (CMO) ChartBeijing Wantai Biological Pharmacy Enterprise Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Beijing Wantai Biological Pharmacy Enterprise Co Ltd. The current willr is -93.20066335.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Daily Williams %R ChartBeijing Wantai Biological Pharmacy Enterprise Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Beijing Wantai Biological Pharmacy Enterprise Co Ltd.

Beijing Wantai Biological Pharmacy Enterprise Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Beijing Wantai Biological Pharmacy Enterprise Co Ltd. The current atr is 3.74721758.

Beijing Wantai Biological Pharmacy Enterprise Co Ltd Daily Average True Range (ATR) ChartBeijing Wantai Biological Pharmacy Enterprise Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Beijing Wantai Biological Pharmacy Enterprise Co Ltd. The current obv is -115,664,387.

Beijing Wantai Biological Pharmacy Enterprise Co Ltd Daily On-Balance Volume (OBV) ChartBeijing Wantai Biological Pharmacy Enterprise Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Beijing Wantai Biological Pharmacy Enterprise Co Ltd. The current mfi is 35.14.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Daily Money Flow Index (MFI) ChartBeijing Wantai Biological Pharmacy Enterprise Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Beijing Wantai Biological Pharmacy Enterprise Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-21ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-25ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-26ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-29ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Beijing Wantai Biological Pharmacy Enterprise Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Beijing Wantai Biological Pharmacy Enterprise Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.373
Ma 20Greater thanMa 5068.563
Ma 50Greater thanMa 10068.975
Ma 100Greater thanMa 20065.105
OpenGreater thanClose66.050
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Beijing Wantai Biological Pharmacy Enterprise Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Beijing Wantai Biological Pharmacy Enterprise Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Beijing Wantai Biological Pharmacy Enterprise Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Beijing Wantai Biological Pharmacy Enterprise Co Ltd

I send you an email if I find something interesting about Beijing Wantai Biological Pharmacy Enterprise Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Beijing Wantai Biological Pharmacy Enterprise Co Ltd.

Receive notifications about Beijing Wantai Biological Pharmacy Enterprise Co Ltd in your mailbox!